By expenditures
| Name | Title | Type |
|---|---|---|
| Deborah Rezene | Director of Financial Aid | Auditee |
| Alison Hayes | Interim Director of Financial Aid | Auditee |
| Christopher Gordon, Cpa | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 337234 | 2024 | 2025-01-10 | Capincrouse LLP | $9.88M |
| 292694 | 2023 | 2024-02-28 | Capincrouse LLP | $10.75M |
| 21005 | 2022 | 2023-02-14 | Capincrouse LLP | $16.96M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 337234 | 2024 | 2025-01-10 | 1095296 | 2024-004 | - | Yes | E |
| 337234 | 2024 | 2025-01-10 | 1095295 | 2024-003 | - | - | L |
| 337234 | 2024 | 2025-01-10 | 1095294 | 2024-002 | Significant Deficiency | - | N |
| 337234 | 2024 | 2025-01-10 | 1095293 | 2024-002 | Significant Deficiency | - | N |
| 337234 | 2024 | 2025-01-10 | 1095292 | 2024-001 | Material Weakness | Yes | N |
| 337234 | 2024 | 2025-01-10 | 1095291 | 2024-001 | Material Weakness | Yes | N |
| 337234 | 2024 | 2025-01-10 | 518854 | 2024-004 | - | Yes | E |
| 337234 | 2024 | 2025-01-10 | 518853 | 2024-003 | - | - | L |
| 337234 | 2024 | 2025-01-10 | 518852 | 2024-002 | Significant Deficiency | - | N |
| 337234 | 2024 | 2025-01-10 | 518851 | 2024-002 | Significant Deficiency | - | N |
| 337234 | 2024 | 2025-01-10 | 518850 | 2024-001 | Material Weakness | Yes | N |
| 337234 | 2024 | 2025-01-10 | 518849 | 2024-001 | Material Weakness | Yes | N |
| 292694 | 2023 | 2024-02-28 | 947481 | 2023-004 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 947480 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 947479 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 947478 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 947477 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 947476 | 2023-002 | Significant Deficiency | Yes | N |
| 292694 | 2023 | 2024-02-28 | 947475 | 2023-002 | Significant Deficiency | Yes | N |
| 292694 | 2023 | 2024-02-28 | 947474 | 2023-001 | Significant Deficiency | - | L |
| 292694 | 2023 | 2024-02-28 | 947473 | 2023-001 | Significant Deficiency | - | L |
| 292694 | 2023 | 2024-02-28 | 371039 | 2023-004 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 371038 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 371037 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 371036 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 371035 | 2023-003 | - | - | N |
| 292694 | 2023 | 2024-02-28 | 371034 | 2023-002 | Significant Deficiency | Yes | N |
| 292694 | 2023 | 2024-02-28 | 371033 | 2023-002 | Significant Deficiency | Yes | N |
| 292694 | 2023 | 2024-02-28 | 371032 | 2023-001 | Significant Deficiency | - | L |
| 292694 | 2023 | 2024-02-28 | 371031 | 2023-001 | Significant Deficiency | - | L |
| 21005 | 2022 | 2023-02-14 | 601711 | 2022-002 | - | - | L |
| 21005 | 2022 | 2023-02-14 | 601710 | 2022-001 | Material Weakness | - | N |
| 21005 | 2022 | 2023-02-14 | 601709 | 2022-001 | Material Weakness | - | N |
| 21005 | 2022 | 2023-02-14 | 601708 | 2022-001 | Material Weakness | - | N |
| 21005 | 2022 | 2023-02-14 | 25269 | 2022-002 | - | - | L |
| 21005 | 2022 | 2023-02-14 | 25268 | 2022-001 | Material Weakness | - | N |
| 21005 | 2022 | 2023-02-14 | 25267 | 2022-001 | Material Weakness | - | N |
| 21005 | 2022 | 2023-02-14 | 25266 | 2022-001 | Material Weakness | - | N |